Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.50 |
| ▸ | CES1 | P23141 | 5/20 | 0.50 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7085256 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL17540757 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2827903 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2733841 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL25300764 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2734708 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL25299017 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL1286332 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL16721005 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9754723 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132906-A1 | FOCUSED ULTRASOUND THERMAL ABLATION WITH THERMAL ENHANCERS | BRACCO SUISSE SA (CH) | 2025-06-26 | — | — | WO | claimed |
| EP-2198894-B1 | Polymethylmethacrylate-bone cement compound for controlled hyperthermia treatment | HERAEUS MEDICAL GMBH (DE) | 2017-03-15 | — | — | EP | claimed |
| US-20100160483-A1 | POLYMETHYLMETHACRYLATE BONE CEMENT COMPOSITION FOR CONTROLLED HYPERTHERMIA TREATMENT | HERAEUS MEDICAL GMBH (DE) | 2010-06-24 | — | — | US | claimed |
| EP-2198894-A2 | Polymethylmethacrylate-bone cement compound for controlled hyperthermia treatment | Heraeus Medical GmbH (DE) | 2010-06-23 | — | — | EP | claimed |
| CN-115298270-B | Method for preparing thermochromic water-based gel ink composition and thermochromic water-based gel ink composition thereof | 法国比克公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-115298270-A | Method for preparing thermochromic water-based gel ink composition and thermochromic water-based gel ink composition thereof | 法国比克公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-2198894-B1 | Polymethylmethacrylate-bone cement compound for controlled hyperthermia treatment | HERAEUS MEDICAL GMBH (DE) | 2017-03-15 | — | — | EP | disclosed |
| US-20100160483-A1 | POLYMETHYLMETHACRYLATE BONE CEMENT COMPOSITION FOR CONTROLLED HYPERTHERMIA TREATMENT | HERAEUS MEDICAL GMBH (DE) | 2010-06-24 | — | — | US | disclosed |
| EP-2198894-A2 | Polymethylmethacrylate-bone cement compound for controlled hyperthermia treatment | Heraeus Medical GmbH (DE) | 2010-06-23 | — | — | EP | disclosed |
| WO-1991007168-A1 | RIBOFLAVIN AS A TANNING ENHANCER | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |